Muneer A. Satter
@Alerce Investment Management, L.p.
Latest period2024 - Q3ReportedManaged Assets$62.321MTotal holdings5
Assets growth rate-99.87%Assets growth rate (2-Q avg)26727.56%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Alerce Investment Management, L.p.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 5 positions.
Assets under management
The assets under management (AUM) of Alerce Investment Management, L.p. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 62.321M in assets, with a quarterly growth rate of -99.87% and a 2-quarter average growth rate of 26727.56%. The portfolio is managed by Muneer A. Satter, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
ANNXAnnexon Inc
| 70.36% | $43.844M 7.406M shares@ $5.92 avg price | |
AKBAAkebia Therapeutics Inc
| 12.18% | $7.587M 5.748M shares@ $1.33 avg price | |
VRNAVerona Pharma Plc
| 9.51% | $5.923M 205,880 shares@ $28.78 avg price | Decreased -3.34% |
AMWLAmerican Well Corp
| 7.97% | $4.965M 523,785 shares@ $9.49 avg price | New Position |
AADIAadi Bioscience Inc
| 0.01% | $1,358 659 shares@ $2.07 avg price | Decreased -99.95% |